GlassScriptPhysician profile
Arunpreet Kahlon
NPI 1437582202
$36,873.94
in general payments reported to CMS, 2019-2025
50 companies · $10K in 2025
The $10K reported for 2025 was more than what 89% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.09 · 2020: $454 · 2021: $1,390 · 2022: $11K · 2023: $4,190 · 2024: $9,321 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $9,564 · Travel and Lodging: $1,206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,000.00 |
| Food and Beverage | $9,563.79 |
| Travel and Lodging | $1,206.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $16,311.89 | 2022-2025 | Indigo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $7,267.73 | 2022-2025 | Lifevest |
| Medtronic, INC. | $1,904.92 | 2022-2025 | Onyx Frontier, Symplicity G3, Telescope |
| Abbott Laboratories | $1,414.93 | 2020-2023 | Mitraclip |
| Boston Scientific Corporation | $1,323.71 | 2020-2024 | Varithena Administration Pack |
| Inari Medical, INC. | $1,192.74 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Edwards Lifesciences Corporation | $885.01 | 2021-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Novartis Pharmaceuticals Corporation | $718.65 | 2021-2025 | |
| Heartflow, INC. | $474.44 | 2024-2025 | |
| Novo Nordisk INC | $468.95 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $403.24 | 2021-2025 | |
| Amgen INC. | $369.02 | 2021-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $312.33 | 2022-2025 | Wainua, Farxiga, Lokelma |
| Boehringer Ingelheim Pharmaceuticals, INC. | $302.87 | 2021-2025 | Jardiance |
| Abiomed | $279.15 | 2023-2025 | Impella |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $262.68 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $259.14 | 2022-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $257.34 | 2023-2025 | Verquvo |
| Bridgebio Pharma, INC. | $217.96 | 2025 | Attruby |
| Philips North America LLC | $205.23 | 2022-2024 | (Br4) Coronary Undivided, (5091) Amb Mon & Diag Und |
| Scpharmaceuticals INC. | $187.84 | 2024-2025 | |
| Teleflex LLC | $170.16 | 2022 | |
| Cleerly, INC. | $161.79 | 2024-2025 | Cleerly Labs, Cleerly Ischemia |
| Kestra Medical Technology Services, INC. | $136.24 | 2022-2025 | Assure Wcd |
| Cvrx, INC. | $125.05 | 2023-2025 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $124.27 | 2022-2024 | |
| Alnylam Pharmaceuticals INC. | $91.81 | 2023-2025 | Amvuttra |
| Gilead Sciences, INC. | $88.60 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $82.84 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $77.76 | 2021-2025 | Nexletol |
| W. L. Gore & Associates, INC. | $74.30 | 2023-2025 | Gore Cardioform Septal Occluder |
| Impulse Dynamics (USA) INC. | $72.90 | 2023 | Optimizer |
| Janssen Pharmaceuticals, INC | $72.50 | 2022-2024 | Xarelto |
| Kiniksa Pharmaceuticals, LTD. | $67.57 | 2022-2023 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $58.05 | 2023-2024 | Inpefa |
| Lilly USA, LLC | $48.72 | 2024-2025 | Zepbound, Mounjaro |
| Stryker Corporation | $47.57 | 2025 | Flowtriever |
| Ionis Pharmaceuticals, INC. | $46.05 | 2025 | Tryngolza |
| Bayer Healthcare Pharmaceuticals INC. | $42.62 | 2025 | |
| Genzyme Corporation | $39.23 | 2023 | |
| Biotronik INC. | $36.72 | 2022 | |
| Medtronic Vascular, INC. | $31.38 | 2020 | |
| Cardiovascular Systems INC. | $27.50 | 2019-2020 | |
| Recor Medical INC | $24.39 | 2024 | Paradise Renal Denervation System |
| Terumo Medical Corporation | $22.81 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $22.75 | 2025 | Opsumit |
| Glaxosmithkline, LLC. | $21.46 | 2024 | Shingrix, Arexvy |
| Bard Peripheral Vascular, INC. | $20.91 | 2023 | Venclose Maven Catheter |
| Astellas Pharma US INC | $18.22 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$50,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arunpreet Kahlon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.